Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Leung

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Histopathology|October 17, 2018
Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcomeLinyuan Wang, Peter F Rambau, Linda E Kelemen, et al.
Breast Cancer Research : BCR|January 16, 2010
Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancerYue Sun, Dmitry A Turbin, Kun Ling, et al.
Annals of Surgery|May 21, 2010
HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patientsConnie G Chiu, Hamid Masoudi, Samuel Leung, et al.
Breast Cancer Research and Treatment|April 20, 2011
FOXA1 is an independent prognostic marker for ER-positive breast cancerRutika J Mehta, Rohit K Jain, Samuel Leung, et al.
BMC Cancer|May 30, 2009
Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysisGulisa Turashvili, Samuel Leung, Dmitry Turbin, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 17, 2007
Clinicopathologic factors and nuclear morphometry as independent prognosticators in KIT-positive gastrointestinal stromal tumorsSonja E Steigen, Bjørn Straume, Dmitry Turbin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2009
BCL-2 expression is prognostic for improved survival in non-small cell lung cancerDaniel J Renouf, Richard Wood-Baker, Diana N Ionescu, et al.
Breast Cancer Research and Treatment|February 12, 2009
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patientsShuzhen Liu, Stephen K Chia, Erika Mehl, et al.
Breast Cancer Research and Treatment|July 29, 2009
Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancersLindsay A Brown, Karynn Johnson, Samuel Leung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 28, 2019
Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinomaLily Proctor, Lien Hoang, Jocelyn Moore, et al.
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Histopathology|October 17, 2018
Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcomeLinyuan Wang, Peter F Rambau, Linda E Kelemen, et al.
Breast Cancer Research : BCR|January 16, 2010
Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancerYue Sun, Dmitry A Turbin, Kun Ling, et al.
Annals of Surgery|May 21, 2010
HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patientsConnie G Chiu, Hamid Masoudi, Samuel Leung, et al.
Breast Cancer Research and Treatment|April 20, 2011
FOXA1 is an independent prognostic marker for ER-positive breast cancerRutika J Mehta, Rohit K Jain, Samuel Leung, et al.
BMC Cancer|May 30, 2009
Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysisGulisa Turashvili, Samuel Leung, Dmitry Turbin, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 17, 2007
Clinicopathologic factors and nuclear morphometry as independent prognosticators in KIT-positive gastrointestinal stromal tumorsSonja E Steigen, Bjørn Straume, Dmitry Turbin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2009
BCL-2 expression is prognostic for improved survival in non-small cell lung cancerDaniel J Renouf, Richard Wood-Baker, Diana N Ionescu, et al.
Breast Cancer Research and Treatment|February 12, 2009
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patientsShuzhen Liu, Stephen K Chia, Erika Mehl, et al.
Breast Cancer Research and Treatment|July 29, 2009
Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancersLindsay A Brown, Karynn Johnson, Samuel Leung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 28, 2019
Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinomaLily Proctor, Lien Hoang, Jocelyn Moore, et al.
Pageof 13